Home > Financial Ratios > SUN PHARMA ADVANCED RESEARCH COMPANY

SUN PHARMA ADVANCED RESEARCH COMPANY
Core EBITDA Growth

    Back to All Ratios
SUN PHARMA ADVANCED RESEARCH COMPANY is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SUN PHARMA ADVANCED RESEARCH COMPANY
Please provide your vote to see the results

SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023
   Core EBITDA Growth(%) -83.40-

What is the latest Core EBITDA Growth ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?

The latest Core EBITDA Growth ratio of SUN PHARMA ADVANCED RESEARCH COMPANY is -83.40 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar2024-83.40
Mar2023-

How is Core EBITDA Growth of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?

Years Core EBITDA Growth % Change
Mar2024 -83.4
0
Mar2023 0 -

Other Financial Ratios of SUN PHARMA ADVANCED RESEARCH COMPANY


Compare Core EBITDA Growth ratio of peers of SUN PHARMA ADVANCED RESEARCH COMPANY

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SUN PHARMA ADVANCED RESEARCH COMPANY ₹5,075.2 Cr -9.3% -9.3% -32.9% Stock Analytics
SYNGENE INTERNATIONAL ₹25,463.8 Cr -4% -1.9% -8.9% Stock Analytics
SAGILITY INDIA ₹18,818.9 Cr 3.4% -8.8% NA Stock Analytics
LATENT VIEW ANALYTICS ₹8,315.7 Cr 0.6% -1.6% -19.8% Stock Analytics
JUST DIAL ₹7,457.6 Cr -2.9% -5.3% -15.9% Stock Analytics
AWFIS SPACE SOLUTIONS ₹4,669.4 Cr 0.4% -1.3% 36.8% Stock Analytics


SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SUN PHARMA ADVANCED RESEARCH COMPANY

-9.3%

-9.3%

-32.9%

SENSEX

1.6%

1%

7%


You may also like the below Video Courses